185 related articles for article (PubMed ID: 1649189)
41. Insulin and isoproterenol induce phosphorylation of the particulate cyclic GMP-inhibited, low Km cyclic AMP phosphodiesterase (cGI PDE) in 3T3-L1 adipocytes.
Vasta V; Smith CJ; Calvo J; Belfrage P; Manganiello VC
Biochem Biophys Res Commun; 1992 Mar; 183(3):1070-5. PubMed ID: 1314573
[TBL] [Abstract][Full Text] [Related]
42. Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram.
Michie AM; Lobban M; Müller T; Harnett MM; Houslay MD
Cell Signal; 1996 Feb; 8(2):97-110. PubMed ID: 8730511
[TBL] [Abstract][Full Text] [Related]
43. mRNA expression and antilipolytic role of phosphodiesterase 4 in rat adipocytes in vitro.
Wang H; Edens NK
J Lipid Res; 2007 May; 48(5):1099-107. PubMed ID: 17267946
[TBL] [Abstract][Full Text] [Related]
44. Subcellular localization and hormone sensitivity of adipocyte cyclic AMP phosphodiesterase.
Anderson NG; Kilgour E; Houslay MD
Biochem J; 1989 Sep; 262(3):867-72. PubMed ID: 2556112
[TBL] [Abstract][Full Text] [Related]
45. Stimulation of the insulin-sensitive cAMP phosphodiesterase by an ATP-dependent soluble factor from insulin-treated rat adipocytes.
Shibata H; Kono T
Biochem Biophys Res Commun; 1990 Mar; 167(2):614-20. PubMed ID: 2157411
[TBL] [Abstract][Full Text] [Related]
46. Orthovanadate stimulates cyclic guanosine monophosphate-inhibited cyclic adenosine monophosphate phosphodiesterase activity in isolated rat fat pads through activation of particulate myelin basic protein kinase by protein tyrosine kinase.
Ueki H; Mitsugi S; Kawashima Y; Motoyashiki T; Morita T
Endocrinology; 1997 Jul; 138(7):2784-9. PubMed ID: 9202218
[TBL] [Abstract][Full Text] [Related]
47. Effect of insulin and lipolytic hormones on cyclic AMP phosphodieterase activity in normal and diabetic rat adipose tissue.
Solomon SS
Endocrinology; 1975 Jun; 96(6):1366-73. PubMed ID: 165058
[TBL] [Abstract][Full Text] [Related]
48. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Suvarna NU; O'Donnell JM
J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
[TBL] [Abstract][Full Text] [Related]
49. Evidence that protein kinase C may not be involved in the insulin action on cAMP phosphodiesterase: studies with electroporated rat adipocytes that were highly responsive to insulin.
Shibata H; Robinson FW; Benzing CF; Kono T
Arch Biochem Biophys; 1991 Feb; 285(1):97-104. PubMed ID: 1846737
[TBL] [Abstract][Full Text] [Related]
50. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
Torphy TJ; Zhou HL; Burman M; Huang LB
Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
[TBL] [Abstract][Full Text] [Related]
51. N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes.
Wallace AV; Heyworth CM; Houslay MD
Biochem J; 1984 Aug; 222(1):177-82. PubMed ID: 6089755
[TBL] [Abstract][Full Text] [Related]
52. cAMP-dependent protein kinase activation mediated by beta 3-adrenergic receptors parallels lipolysis in rat adipocytes.
Langin D; Ekholm D; Ridderstråle M; Lafontan M; Belfrage P
Biochim Biophys Acta; 1992 Jun; 1135(3):349-52. PubMed ID: 1352466
[TBL] [Abstract][Full Text] [Related]
53. Effects of sequence and timing of hormonal additions on adipose tissue: activation of low-Km cyclic adenosine monophosphate phosphodiesterase.
Solomon SS; Palazzolo MR; Duckworth WC
Metabolism; 1991 Sep; 40(9):899-901. PubMed ID: 1654498
[TBL] [Abstract][Full Text] [Related]
54. Characterization of the cyclic nucleotide phosphodiesterase isoenzymes present in rat epididymal fat cells.
Schmitz-Peiffer C; Reeves ML; Denton RM
Cell Signal; 1992 Jan; 4(1):37-49. PubMed ID: 1571203
[TBL] [Abstract][Full Text] [Related]
55. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
Rose RJ; Liu H; Palmer D; Maurice DH
Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
[TBL] [Abstract][Full Text] [Related]
56. Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms.
Kather H; Bieger W; Michel G; Aktories K; Jakobs KH
J Clin Invest; 1985 Oct; 76(4):1559-65. PubMed ID: 2997284
[TBL] [Abstract][Full Text] [Related]
57. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
58. Single-step affinity purification, partial structure and properties of human platelet cGMP inhibited cAMP phosphodiesterase.
Degerman E; Moos M; Rascón A; Vasta V; Meacci E; Smith CJ; Lindgren S; Andersson KE; Belfrage P; Manganiello V
Biochim Biophys Acta; 1994 Apr; 1205(2):189-98. PubMed ID: 8155697
[TBL] [Abstract][Full Text] [Related]
59. Cyclic nucleotide phosphodiesterase. Insulin activation detected in adipose tissue by gel electrophoresis.
Solomon SS; Palazzolo M; King LE
Diabetes; 1977 Oct; 26(10):967-72. PubMed ID: 198322
[TBL] [Abstract][Full Text] [Related]
60. Differential effects of phosphodiesterase PDE-3/PDE-4-specific inhibitors on vasoconstriction and cAMP-dependent vasorelaxation following balloon angioplasty.
Zhao H; Quilley J; Montrose DC; Rajagopalan S; Guan Q; Smith CJ
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2973-81. PubMed ID: 17293498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
